TrialJCI insight2023

Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx.

Michael Crompton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.